Iron and Parkinson's disease.
作者： Di Lorenzo F
DOI:
关键词:
摘要: Parkinson's disease; iron; neurodegeneration; oxidative stress Abstract In this case presentation, a man with diagnosis of disease was treated Chelation Therapy against iron without serum level correla- tion. The patient, who suffered from motor and non-motor symptoms the disease, showed an improved condition after Therapy. This clinical test evaluated UPDRS III score. rationale limits are discussed. suggests that iron-dependent could represent promising therapy for dramatic necessity to deeply study metabolism in neuro-degeneration appears really significant.
参考文章(25)
DouglasJ. Brown, KathrynN. Ham, JohnK. Dawborn, JosephM. Xipell, TREATMENT OF DIALYSIS OSTEOMALACIA WITH DESFERRIOXAMINE The Lancet. ,vol. 320, pp. 343- 345 ,(1982) , 10.1016/S0140-6736(82)90544-X
Luigi Zecca, Moussa B. H. Youdim, Peter Riederer, James R. Connor, Robert R. Crichton, Iron, brain ageing and neurodegenerative disorders Nature Reviews Neuroscience. ,vol. 5, pp. 863- 873 ,(2004) , 10.1038/NRN1537
MARIO E. GÖTZ, KAY DOUBLE, MANFRED GERLACH, MOUSSA B. H. YOUDIM, PETER RIEDERERE, The relevance of iron in the pathogenesis of Parkinson's disease. Annals of the New York Academy of Sciences. ,vol. 1012, pp. 193- 208 ,(2004) , 10.1196/ANNALS.1306.017
Jerome A. Roth, Steven Singleton, Jian Feng, Michael Garrick, Prasad N. Paradkar, Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1 Journal of Neurochemistry. ,vol. 113, pp. 454- 464 ,(2010) , 10.1111/J.1471-4159.2010.06607.X
Luigi Zecca, Luigi Casella, Alberto Albertini, Chiara Bellei, Fabio A. Zucca, Mireille Engelen, Andrzej Zadlo, Grzegorz Szewczyk, Mariusz Zareba, Tadeusz Sarna, Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease Journal of Neurochemistry. ,vol. 106, pp. 1866- 1875 ,(2008) , 10.1111/J.1471-4159.2008.05541.X
Deepinder Kaur, Donna Lee, Subramanian Ragapolan, Julie K. Andersen, Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: Implications for Parkinson's disease Free Radical Biology and Medicine. ,vol. 46, pp. 593- 598 ,(2009) , 10.1016/J.FREERADBIOMED.2008.11.012
J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-Fischer, M. Arredondo, C. Duyckaerts, V. Sazdovitch, L. Zhao, L. M. Garrick, M. T. Nunez, M. D. Garrick, R. Raisman-Vozari, E. C. Hirsch, Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 18578- 18583 ,(2008) , 10.1073/PNAS.0804373105
Richard Ortega, Peter Cloetens, Guillaume Devès, Asunción Carmona, Sylvain Bohic, Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging PLoS ONE. ,vol. 2, pp. e925- ,(2007) , 10.1371/JOURNAL.PONE.0000925
Arno G. Siraki, John Smythies, Peter J. O'Brien, Superoxide radical scavenging and attenuation of hypoxia-reoxygenation injury by neurotransmitter ferric complexes in isolated rat hepatocytes. Neuroscience Letters. ,vol. 296, pp. 37- 40 ,(2000) , 10.1016/S0304-3940(00)01618-9
Gehad G Mohamed, M.A Zayed, F.A.Nour El-Dien, Reham G El-Nahas, IR, UV-Vis, magnetic and thermal characterization of chelates of some catecholamines and 4-aminoantipyrine with Fe(III) and Cu(II). Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. ,vol. 60, pp. 1775- 1781 ,(2004) , 10.1016/J.SAA.2003.08.027